Maria Colorado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Colorado has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Carlos E. Arias-Morales
Department of Medicine, St. Barnabas Hospital , Bronx, NY 10457
1 shared publication - Jose Antonio Gomez Miranda
Facultad de Medicina, Universidad del del Salvador, San Salvador 1101, El Salvador
1 shared publication
Latest Publications
- Open Access
- 19 August 2025
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 3 (10) , luaf195
Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring
Tirzepatide (Zepbound), a novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, demonstrates an additive effect, significantly enhancing insulin secretion compared to administering each hormone separately. The case reports presented here, detailing palpitations, musculoskeletal pain, and headaches following tirzepatide administration, raise important questions about the drug's postmarketing safety profile.
- 19 August 2025
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 3 (10) , luaf195
Open AccessUnanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring
Tirzepatide (Zepbound), a novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, demonstrates an additive effect, significantly enhancing insulin secretion compared to administering each hormone separately. The case reports presented here, detailing palpitations, musculoskeletal pain, and headaches following tirzepatide administration, raise important questions about the drug's postmarketing safety profile.